Nina Lin

3.7k total citations
38 papers, 1.1k citations indexed

About

Nina Lin is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Nina Lin has authored 38 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Infectious Diseases, 21 papers in Virology and 13 papers in Emergency Medicine. Recurrent topics in Nina Lin's work include HIV Research and Treatment (21 papers), HIV/AIDS drug development and treatment (17 papers) and HIV-related health complications and treatments (13 papers). Nina Lin is often cited by papers focused on HIV Research and Treatment (21 papers), HIV/AIDS drug development and treatment (17 papers) and HIV-related health complications and treatments (13 papers). Nina Lin collaborates with scholars based in United States, Botswana and Germany. Nina Lin's co-authors include Kuan-Teh Jeang, Daniel R. Kuritzkes, Anne Gatignol, Charles Glabe, H Fan, Rene F. Chun, Malcolm A. Martin, Boro Dropulić, Manish Sagar and Jennifer Snyder‐Cappione and has published in prestigious journals such as Nucleic Acids Research, Annals of Internal Medicine and The Journal of Immunology.

In The Last Decade

Nina Lin

35 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nina Lin United States 15 645 457 343 272 180 38 1.1k
Maura Manion United States 15 444 0.7× 291 0.6× 144 0.4× 471 1.7× 212 1.2× 50 951
Joseph C. Mudd United States 18 788 1.2× 398 0.9× 205 0.6× 714 2.6× 363 2.0× 35 1.5k
Norma Rallón Spain 22 550 0.9× 402 0.9× 134 0.4× 429 1.6× 620 3.4× 99 1.4k
Brinda Emu United States 15 1.1k 1.7× 717 1.6× 215 0.6× 729 2.7× 394 2.2× 42 1.8k
Richard H. Glashoff South Africa 16 288 0.4× 207 0.5× 187 0.5× 205 0.8× 214 1.2× 46 841
Alessandra Noto Switzerland 13 670 1.0× 323 0.7× 177 0.5× 878 3.2× 287 1.6× 24 1.4k
José M. Benito Spain 26 1.3k 2.0× 821 1.8× 214 0.6× 910 3.3× 838 4.7× 133 2.4k
Betsey Herpin United States 12 591 0.9× 330 0.7× 57 0.2× 417 1.5× 224 1.2× 17 931
Judith Dalmau Spain 15 705 1.1× 471 1.0× 158 0.5× 385 1.4× 162 0.9× 29 940
Gerald Spotts United States 20 351 0.5× 129 0.3× 266 0.8× 362 1.3× 126 0.7× 43 1.7k

Countries citing papers authored by Nina Lin

Since Specialization
Citations

This map shows the geographic impact of Nina Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nina Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nina Lin more than expected).

Fields of papers citing papers by Nina Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nina Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nina Lin. The network helps show where Nina Lin may publish in the future.

Co-authorship network of co-authors of Nina Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Nina Lin. A scholar is included among the top collaborators of Nina Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nina Lin. Nina Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pickering, R. Taylor, et al.. (2025). Increased insulin resistance following switch from efavirenz to cobicistat-boosted elvitegravir. Antiviral Therapy. 30(1). 232040331–232040331.
2.
Pihl, Riley M.F., Alex Olson, Archana Asundi, et al.. (2024). Vδ1 Effector and Vδ2 γδ T-Cell Subsets Shift in Frequency and Are Linked to Plasma Inflammatory Markers During Antiretroviral Therapy-Suppressed HIV Infection. The Journal of Infectious Diseases. 229(5). 1317–1327. 4 indexed citations
3.
Asundi, Archana, Jessica L. Taylor, Samantha Roche, et al.. (2024). HIV-1 latency reversal agent boosting is not limited by opioid use. JCI Insight. 9(22).
4.
Huck, Daniel, Brittany Weber, Sanjay Divakaran, et al.. (2023). Coronary Microcirculatory Dysfunction in People With HIV and Its Association With Antiretroviral Therapy. Journal of the American Heart Association. 12(22). e029541–e029541. 6 indexed citations
5.
Psaros, Christina, Amelia M. Stanton, Greer A. Raggio, et al.. (2022). Adapting, testing, and refining a resilience intervention for older women with HIV: An open pilot study. Journal of Women & Aging. 35(4). 395–415. 2 indexed citations
6.
Erqou, Sebhat, Lan Jiang, Gaurav Choudhary, et al.. (2021). Age at Diagnosis of Heart Failure in United States Veterans With and Without HIV Infection. Journal of the American Heart Association. 10(11). e018983–e018983. 4 indexed citations
7.
Olson, Alex, et al.. (2021). Intragenic proviral elements support transcription of defective HIV-1 proviruses. PLoS Pathogens. 17(12). e1009982–e1009982. 11 indexed citations
8.
Liu, Jing, Nina Lin, Vipul C. Chitalia, et al.. (2021). End-stage kidney disease and COVID-19 in an urban safety-net hospital in Boston, Massachusetts. PLoS ONE. 16(6). e0252679–e0252679. 3 indexed citations
9.
Sinha, Pranay, Davidson H. Hamer, Lee M. Wetzler, et al.. (2020). Early administration of interleukin-6 inhibitors for patients with severe COVID-19 disease is associated with decreased intubation, reduced mortality, and increased discharge. International Journal of Infectious Diseases. 99. 28–33. 52 indexed citations
10.
Ataca, Sila, et al.. (2019). HIV-1 Coreceptor Usage and Variable Loop Contact Impact V3 Loop Broadly Neutralizing Antibody Susceptibility. Journal of Virology. 94(2). 12 indexed citations
11.
Elias, Rawad, Kevan L. Hartshorn, Osama E. Rahma, Nina Lin, & Jennifer Snyder‐Cappione. (2018). Aging, immune senescence, and immunotherapy: A comprehensive review. Seminars in Oncology. 45(4). 187–200. 64 indexed citations
12.
Belkina, Anna C., Alina Starchenko, Katherine Drake, et al.. (2018). Multivariate Computational Analysis of Gamma Delta T Cell Inhibitory Receptor Signatures Reveals the Divergence of Healthy and ART-Suppressed HIV+ Aging. Frontiers in Immunology. 9. 2783–2783. 30 indexed citations
13.
Dong, Krista L., Amber Moodley, Douglas S. Kwon, et al.. (2017). Detection and treatment of Fiebig stage I HIV-1 infection in young at-risk women in South Africa: a prospective cohort study. The Lancet HIV. 5(1). e35–e44. 59 indexed citations
14.
Lin, Nina, Behzad Etemad, Hong Lü, et al.. (2016). Humoral Immune Pressure Selects for HIV-1 CXC-chemokine Receptor 4-using Variants. EBioMedicine. 8. 237–247. 14 indexed citations
15.
Henrich, Timothy J., Zixin Hu, Gaia Sciaranghella, et al.. (2013). Long-Term Reduction in Peripheral Blood HIV Type 1 Reservoirs Following Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation. The Journal of Infectious Diseases. 207(11). 1694–1702. 182 indexed citations
16.
Wilkin, Timothy, Christina M. Lalama, J. Gregory McKinnon, et al.. (2012). A Pilot Trial of Adding Maraviroc to Suppressive Antiretroviral Therapy for Suboptimal CD4+ T-Cell Recovery Despite Sustained Virologic Suppression: ACTG A5256. The Journal of Infectious Diseases. 206(4). 534–542. 60 indexed citations
17.
Lin, Nina, Laura Smeaton, Françoise Giguel, et al.. (2011). Prevalence and Clinical Associations of CXCR4-Using HIV-1 Among Treatment-Naive Subtype C-Infected Women in Botswana. JAIDS Journal of Acquired Immune Deficiency Syndromes. 57(1). 46–50. 14 indexed citations
18.
Henrich, Timothy J., Jonathan Z. Li, Donna Felsenstein, et al.. (2010). Xenotropic Murine Leukemia Virus–Related Virus Prevalence in Patients with Chronic Fatigue Syndrome or Chronic Immunomodulatory Conditions. The Journal of Infectious Diseases. 202(10). 1478–1481. 53 indexed citations
19.
Lin, Nina, Rameen Beroukhim, Françoise Giguel, et al.. (2010). The design and validation of a novel phenotypic assay to determine HIV-1 coreceptor usage of clinical isolates. Journal of Virological Methods. 169(1). 39–46. 22 indexed citations
20.
Hughes, John H., et al.. (1974). Acid Lability of Rhinoviruses: Loss of C and D Antigenicity after Treatment at pH 3.0. The Journal of Immunology. 112(3). 919–925. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maura Manion Breakdown of academic impact, for papers by Joseph C. Mudd Breakdown of academic impact, for papers by Norma Rallón Breakdown of academic impact, for papers by Brinda Emu Breakdown of academic impact, for papers by Richard H. Glashoff Breakdown of academic impact, for papers by Alessandra Noto Breakdown of academic impact, for papers by José M. Benito Breakdown of academic impact, for papers by Betsey Herpin Breakdown of academic impact, for papers by Judith Dalmau Breakdown of academic impact, for papers by Gerald Spotts
Rankless by CCL
2026